The Morning Blunt

Volume 1| Issue 18

September 18, 2018

“More business is lost every year through neglect than any other cause”

— Rose Kennedy

Global Market

Shorting cannabis stocks is becoming an expensive endeavor. Recent supply agreements, mergers, and major investment are some of the reasons stocks are soaring and expected to climb for the next several months. The $1.5 billion short on cannabis stocks is said to be 200 times more expensive than Amazon shorts and costs roughly $2.4 million per day.

Namaste Technologies stands out among most pot stocks as a once ancillary business, an online cannabis accessory store. With artificial intelligence projects like NamasteMD and CannMart.com, and a projected share price of $7, higher than their current market price at $3.55, Namaste is expected to rise to the top. Take a look for a deeper analysis.

With astronomically high company valuations in the cannabis industry, Keith Speights predicts that the canna bubble will pop in not too distant of a future. Taking a look at the price to sales ratio analysis, Speights predicts destabilization to occur unless companies consolidate, the US legalizes cannabis, or international markets grow to capacity.

Small to medium cannabis firms in the US and Canadian sectors are looking to consolidate in hopes of gaining solid footing in the volatile cannabis market. Most companies are looking to increase their footprint through M&As. Big Canna is seizing this opportunity, gobbling up as much of the market as possible.

By definition cannabis is a consumer staple with a global estimated worth of over $22 billion by 2022. Stigma is dropping away from the consumer product and a rebranding of cannabis is coinciding with legalization. Because people are unwilling to cut staples out of their lives, it’s expected that greater and more stable returns can be projected.

Coca Cola announced that they have been monitoring the cannabis industry for opportunities which could lead to a new product line of CBD infused health drinks. Aurora and Coca Cola declined comment on whether the companies intend to work together at this juncture. Stocks and news outlets surged with the notion.

With Tilray Inc surging forward 350% this last month and Organigram jumped 50% who is the better investment? Check out how these stocks compare against each other.

Share this: Twitter

Facebook

LinkedIn

Reddit

Pocket

Tumblr

Email



Like this: Like Loading...